Dr. Hien Liu, MD
Claim this profileMoffitt Cancer Center
Studies Mantle Cell Lymphoma
Studies Acute Myelogenous Leukemia
7 reported clinical trials
12 drugs studied
Area of expertise
1Mantle Cell Lymphoma
CCND1 positive
t(11;14) positive
T315I positive
2Acute Myelogenous Leukemia
T315I positive
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Hien Liu, MD is currently running
Ruxolitinib vs Prednisone
for Graft-versus-Host Disease
Allogeneic transplant is potentially curative for hematological malignancies but its use is limited by the development of GVHD. Ruxolitinib now has FDA approval for treatment of chronic GVHD that has failed 1-2 prior lines of therapy based on a prior large, randomized phase III study. Given this evidence of safety and efficacy in the early refractory setting (after prednisone failure), Ruxolitinib represents an ideal agent to test in the primary therapy setting. Here investigators propose a phase 2 randomized study to compare Ruxolitinib to prednisone as a first-line therapy in the treatment of chronic GVHD.
Recruiting1 award Phase 23 criteria
Itacitinib + CAR T-Cell Therapy
for Lymphoma
The purpose of the study is to assess the safety and efficacy of once daily itacitinib oral administration in participants with diffuse large B-cell lymphoma (DLBCL) who will receive CAR-T cell therapy with axicabtagene ciloleucel (axi-cel).
Recruiting1 award Phase 2
More about Hien Liu, MD
Clinical Trial Related8 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Hien Liu, MD has experience with
- Autologous Hematopoietic Stem Cell Transplantation
- Rituximab
- Gamma Delta T-Cell Infusion
- Fludarabine
- Melphalan
- Total Body Irradiation
Breakdown of trials Hien Liu, MD has run
Mantle Cell Lymphoma
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Myeloproliferative Disorder
Myeloproliferative Neoplasms
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hien Liu, MD specialize in?
Hien Liu, MD focuses on Mantle Cell Lymphoma and Acute Myelogenous Leukemia. In particular, much of their work with Mantle Cell Lymphoma has involved CCND1 positive patients, or patients who are t(11;14) positive.
Is Hien Liu, MD currently recruiting for clinical trials?
Yes, Hien Liu, MD is currently recruiting for 2 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Hien Liu, MD has studied deeply?
Yes, Hien Liu, MD has studied treatments such as Autologous Hematopoietic Stem Cell Transplantation, Rituximab, Gamma Delta T-Cell Infusion.
What is the best way to schedule an appointment with Hien Liu, MD?
Apply for one of the trials that Hien Liu, MD is conducting.
What is the office address of Hien Liu, MD?
The office of Hien Liu, MD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.